Asset Details
Do you wish to reserve the book?
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Do you wish to request the book?
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
2021
Overview
Suppressing infections of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will probably require the rapid identification and isolation of individuals infected with the virus on an ongoing basis. Reverse-transcription polymerase chain reaction (RT–PCR) tests are accurate but costly, which makes the regular testing of every individual expensive. These costs are a challenge for all countries around the world, but particularly for low-to-middle-income countries. Cost reductions can be achieved by pooling (or combining) subsamples and testing them in groups
1
–
7
. A balance must be struck between increasing the group size and retaining test sensitivity, as sample dilution increases the likelihood of false-negative test results for individuals with a low viral load in the sampled region at the time of the test
8
. Similarly, minimizing the number of tests to reduce costs must be balanced against minimizing the time that testing takes, to reduce the spread of the infection. Here we propose an algorithm for pooling subsamples based on the geometry of a hypercube that, at low prevalence, accurately identifies individuals infected with SARS-CoV-2 in a small number of tests and few rounds of testing. We discuss the optimal group size and explain why, given the highly infectious nature of the disease, largely parallel searches are preferred. We report proof-of-concept experiments in which a positive subsample was detected even when diluted 100-fold with negative subsamples (compared with 30–48-fold dilutions described in previous studies
9
–
11
). We quantify the loss of sensitivity due to dilution and discuss how it may be mitigated by the frequent re-testing of groups, for example. With the use of these methods, the cost of mass testing could be reduced by a large factor. At low prevalence, the costs decrease in rough proportion to the prevalence. Field trials of our approach are under way in Rwanda and South Africa. The use of group testing on a massive scale to monitor infection rates closely and continually in a population, along with the rapid and effective isolation of people with SARS-CoV-2 infections, provides a promising pathway towards the long-term control of coronavirus disease 2019 (COVID-19).
A mathematical algorithm for population-wide screening of SARS-CoV-2 infections using pooled parallel RT–PCR tests requires considerably fewer tests than individual testing procedures and has minimal delays in the identification of individuals infected with SARS-CoV-2.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Research
Subject
/ 45/77
/ COVID-19
/ COVID-19 Nucleic Acid Testing
/ COVID-19 Nucleic Acid Testing - methods
/ Dilution
/ Genetics & genetic processes
/ Génétique & processus génétiques
/ Humanities and Social Sciences
/ Humans
/ Methods
/ Population Surveillance - methods
/ Prevalence studies (Epidemiology)
/ Rwanda
/ SARS-CoV-2 - isolation & purification
/ Science
